risks of using semaglutide Recent study at UC Irvine found that medication may benefit 93 million U.S. adults Semaglutide linked to reduced risk

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study

The medicines regulator said it will keep the safety and effectiveness of Wegovy under close review, adding that patients with suspected side effects should speak to their pharmacist, doctor or nurse and report it via the Yelllow Card scheme.

Among these, GLP-1 receptor agonists have gained attention for their ability to support weight loss and improve metabolic health

Compounding pharmacies maintain strict quality standards, though compounded medications are not FDA-approved in the way brand-name drugs are